From April 1, 2024 to June 30, 2024, the company has repurchased 16,930,590 shares, representing 3.3% for CNY 161.11 million. With this, the company has completed the repurchase of 37,103,398 shares, representing 7.09% for CNY 404.77 million under the buyback announced on November 20, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.31 CNY | +0.36% |
|
+3.36% | -38.12% |
07-03 | Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023. | CI |
06-12 | ChenGuang Biotech Group Co., Ltd. announces an Increase in Equity Buyback. | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.12% | 585M | |
-5.01% | 273B | |
-9.11% | 86.32B | |
-0.48% | 41B | |
-11.20% | 39.21B | |
+1.89% | 38.21B | |
-3.44% | 35.09B | |
-10.61% | 31.35B | |
-1.97% | 30.03B | |
+4.10% | 23.79B |
- Stock Market
- Equities
- 300138 Stock
- News ChenGuang Biotech Group Co., Ltd.
- Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023.